SK Chemicals’ Vimsk Tab’ became first epilepsy treatment applied for Korean insurance benefit

The SK Chemicals’ epilepsy therapy will be able to secure peerless price competitiveness as registered in Korea for the first time among other same substance products.

SK Chemicals announced ‘Vimsk Tab,’ the first Korean generic of the next generation epilepsy therapy ‘Vimpat Tab(generic name: lacosamide),’ was registered in the list of health insurance benefits from the Ministry of Health and...